Paramount Global Says Nickelodeon Added Spin Master's Unicorn Academy and Vida the Vet to July Lineup, Marking US Linear Debuts on Nickelodeon and Nick Jr.
TAO Synergies Inc TAOX
$2.58
βΌ -5.15%
($-0.14)
🎈 Low Float
📅 Earnings This Week
Open
$2.68
Prev Close
$2.72
Day Range
$2.52 β $2.75
52W Range
$2.17 β $8.77
Market Cap
$21.88M
Beta
1.84
EPS (TTM)
$-3.38
π Company Profile
| Industry | Technology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-12-07 |
| Shares Out. | 7,480,000 |
| Website | synaptogen.com/ β |
| Phone | 13026587581 |
| Employees | 4 |
| Revenue | $88,626 |
| Gross Profit | $88,626 |
| Net Income | -$9.3M |
| Free Cash Flow | -$6.2M |
| Total Assets | $21.1M |
| Total Liabilities | $3.8M |
| Equity | $12.7M |
About TAO Synergies Inc
TAO Synergies Inc is mainly focused on developing a product platform based on its drug candidate, Bryostatin-1, for the treatment of Alzheimer's disease. The company is also evaluating Bryostatin-1 for other neurodegenerative and cognitive conditions, including Fragile X syndrome and Multiple Sclerosis, which have progressed through pre-clinical testing.
TAO Synergies Inc is a publicly traded company under the ticker symbol TAOX on the NASDAQ NMS - GLOBAL MARKET, operating in the Technology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
π Analyst Ratings
7 analysts (2025-04-01)

